glp-1 and vision loss Ozempic Blindness: Should You Worry? GLP-1 medications and eye problem

GLP-1 peptides are poised to revolutionize the treatment of metabolic and chronic diseases

Adult patients 18 years and older For adults, Aetna may approve Saxenda for coverage if certain criteria are met, including: Active participation in a weight management program which includes a reduced-calorie diet and exercise Age 18 or older, with an FDA-approved indication Use of only one weight loss drug at a time No contraindications for using Saxenda Additionally, the patient must meet one of the following criteria: Diagnosis of morbid obesity (BMI of 40 or more)

According to the CDC, there are 178,000 annual deaths linked to excessive drinking

Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, and Petrie JR

Compounded vs FDA-approved branded medications Sprout dispenses compounded semaglutide and compounded tirzepatide pharmacy-prepared formulations of the same active ingredients in Wegovy, Ozempic, Mounjaro, and Zepbound, prepared by U.S